Surface Oncology Asking to Open Trial of Antibody Therapy for Advanced Solid Cancers
News
Surface Oncology is requesting approval to open a Phase 1/1b clinical trial testing SRF617, an anti-CD39 antibody, either alone or in combination with other cancer immunotherapies in people with advanced solid tumors. ... Read more